Epigenetic regulation of epithelial to mesenchymal transition by the Lysine specific demethylase LSD1/KDM1A

被引:46
|
作者
Ambrosio, Susanna [1 ]
Sacca, Carmen D. [1 ]
Majello, Barbara [1 ]
机构
[1] Univ Naples Federico II, Dept Biol, Naples, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS | 2017年 / 1860卷 / 09期
关键词
EMT; LSD1; Chromatin; Cell migration and invasion; Cancer; HISTONE DEMETHYLASE; TRANSCRIPTIONAL REPRESSION; LSD1; CANCER; METASTASIS; INHIBITION; PHOSPHORYLATION; COREST; GENES; EMT;
D O I
10.1016/j.bbagrm.2017.07.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Lysine-specific demethylase 1, KDM1A/LSD1, plays a central role in the regulation of Pol II transcription through the removal of the activation mark (mono- and dimethyl lysine 4 of histone H3). LSD1 is often deregulated in human cancers, and it is frequently overexpressed in human solid cancers and leukemia. LSD1 regulates the epithelial mesenchymal transition (EMT) in epithelial cells, i.e., the ability to transition into mesenchymal cells, to lose homotypic adhesion and to acquire migratory capacity. From its initial discovery as a component of the Snail complex, multiple studies highlighted the causative role of LSD1 in cell invasiveness and EMT, describing its direct involvement in different molecular processes through the interaction with specific partners. Here we present an overview of the role of LSD1 in the EMT process, summarizing recent findings on its emerging functions in cell migration and invasion in cancer.
引用
收藏
页码:905 / 910
页数:6
相关论文
共 50 条
  • [31] LSD1/KDM1A inhibitors in clinical trials: advances and prospects
    Fang, Yuan
    Liao, Guochao
    Yu, Bin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [32] Nonpeptidic Propargylamines as Inhibitors of Lysine Specific Demethylase 1 (LSD1) with Cellular Activity
    Schmitt, Martin L.
    Hauser, Alexander-Thomas
    Carlino, Luca
    Pippel, Martin
    Schulz-Fincke, Johannes
    Metzger, Eric
    Willmann, Dominica
    Yiu, Teresa
    Barton, Michelle
    Schuele, Roland
    Sippl, Wolfgang
    Jung, Manfred
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (18) : 7334 - 7342
  • [33] Lysine-Specific Demethylase 1 (LSD1)-Mediated Epigenetic Modification of Immunogenicity and Immunomodulatory Effects in Breast Cancers
    Lee, Dong Yeul
    Salahuddin, Talha
    Iqbal, Jabed
    CURRENT ONCOLOGY, 2023, 30 (02) : 2127 - 2143
  • [34] Endogenous retroviruses and neighboring genes are coordinately repressed by LSD1/KDM1A
    Macfarlan, Todd S.
    Gifford, Wesley D.
    Agarwal, Saurabh
    Driscoll, Shawn
    Lettieri, Karen
    Wang, Jianxun
    Andrews, Shane E.
    Franco, Laura
    Rosenfeld, Michael G.
    Ren, Bing
    Pfaff, Samuel L.
    GENES & DEVELOPMENT, 2011, 25 (06) : 594 - 607
  • [35] Deletion of histone demethylase Lsd1 (Kdm1a) during retinal development leads to defects in retinal function and structure
    Ferdous, Salma
    Shelton, Debresha A.
    Getz, Tatiana E.
    Chrenek, Micah A.
    L'Hernault, Nancy
    Sellers, Jana T.
    Summers, Vivian R.
    Iuvone, P. Michael
    Boss, Jeremy M.
    Boatright, Jeffrey H.
    Nickerson, John M.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17
  • [36] Polymyxins and quinazolines are LSD1/KDM1A inhibitors with unusual structural features
    Speranzini, Valentina
    Rotili, Dante
    Ciossani, Giuseppe
    Pilotto, Simona
    Marrocco, Biagina
    Forgione, Mariantonietta
    Lucidi, Alessia
    Forneris, Federico
    Mehdipour, Parinaz
    Velankar, Sameer
    Mai, Antonello
    Mattevi, Andrea
    SCIENCE ADVANCES, 2016, 2 (09):
  • [37] Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response
    Pishas, Kathleen I.
    Drenberg, Christina D.
    Taslim, Cenny
    Theisen, Emily R.
    Johnson, Kirsten M.
    Saund, Ranajeet S.
    Pop, Ioana L.
    Crompton, Brian D.
    Lawlor, Elizabeth R.
    Tirode, Franck
    Mora, Jaume
    Delattre, Olivier
    Beckerle, Mary C.
    Callen, David F.
    Sharma, Sunil
    Lessnick, Stephen L.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (09) : 1902 - 1916
  • [38] KDM1A/LSD1 as a promising target in various diseases treatment by regulating autophagy network
    Ma, Ting
    Li, Anqi
    Guo, Yueyang
    Li, Shaotong
    Li, Meng
    Feng, Siqi
    Liu, Hongmin
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 148
  • [39] Requirement of the histone demethylase LSD1 in Snail-mediated transcriptional repression during epithelial-mesenchymal transition
    Lin, T.
    Ponn, A.
    Hu, X.
    Law, B. K.
    Lu, J.
    ONCOGENE, 2010, 29 (35) : 4896 - 4904
  • [40] Lysine-Specific Demethylase 1 (LSD1) Inhibitors: Peptides as an Emerging Class of Therapeutics
    Baby, Stephin
    Shinde, Suchita Dattatray
    Kulkarni, Neeraj
    Sahu, Bichismita
    ACS CHEMICAL BIOLOGY, 2023, 18 (10) : 2144 - 2155